semaglutide 0.5mg side effects New of (Ozempic & Wegovy): Symptoms, Risks and Safety Safety & Side Effects |

They are classified as food supplements and are not part of standard NHS obesity treatment pathways, which prioritise lifestyle modification and licensed medications such as orlistat or semaglutide

Summary: GLP-1 receptor agonists produce modest reductions in total cholesterol, LDL cholesterol, and triglycerides, but are not licensed or recommended as primary treatments for dyslipidaemia

For compounding pharmacies and custom formulation facilities, this means careful planning of production batches to minimize waste while ensuring fresh, potent product reaches end users

:

Fifteen percent experienced measurable B12 decline

See our guide on affordable compounded semaglutide for realistic pricing expectations